• Login
    ARAN - Access to Research at NUI Galway
    Search 
    •   ARAN Home
    • Research Institutes and Centres
    • Regenerative Medicine Institute (REMEDI)
    • Search
    •   ARAN Home
    • Research Institutes and Centres
    • Regenerative Medicine Institute (REMEDI)
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ARANCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypesThis CommunityBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Help

    How to submit and FAQs

    Discover

    AuthorGriffin, Matthew D. (7)Islam, Md Nahidul (2)Marchese, Pietro (2)O'Brien, Timothy (2)O’Connell, Enda (2)... View MoreSubjectSTEM-CELLS (3)DENDRITIC CELLS (2)Inflammation (2)marine fungi (2)Sepsis (2)... View MoreDate Issued2021 (3)2020 (8)TypeArticle (11)

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 11

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Diversity and bioactivity of fungi associated with the marine sea cucumber Holothuria poli: disclosing the strains potential for biomedical applications 

    Marchese, Pietro; Garzolib, Laura; Gnavib, Giorgio; O’Connell, Enda; Bouraouid, Abderrahman; Mehirie, Mohamed; Murphy, Mary; Varese, Giovanna Cristina (Society for Applied Microbiology (SfAM), 2020-04-10)
    Aims: Identification of the mycobiota associated to the marine echinoderm Holothuria poli and investigation of cytotoxic and pro-osteogenic potential of isolated strains. Methods and results: Fungal strains were isolated ...
    Thumbnail

    A novel high-throughput screening platform identifies itaconate derivatives from marine Penicillium antarcticum as inhibitors of mesenchymal stem cell differentiation 

    Marchese, Pietro; Mahajan, Nipun; O’Connell, Enda; Fearnhead, Howard; Tuohy, Maria; Krawczyk, Janusz; Thomas, Olivier P.; Barry, Frank; Murphy, Mary J. (MDPI, 2020-04-05)
    Worldwide diffused diseases such as osteoarthritis, atherosclerosis or chronic kidney disease are associated with a tissue calcification process which may involve unexpected local stem cell differentiation. Current ...
    Thumbnail

    The secretome derived from mesenchymal stromal cells cultured in a xeno-free medium promotes human cartilage recovery in vitro 

    Palama, Maria Elisabetta Federica; Shaw, Georgina Margaret; Carluccio, Simonetta; Reverberi, Daniele; Sercia, Laura; Persano, Luana; Pisignano, Dario; Cortese, Katia; Barry, Francis Peter; Murphy, Josephine Mary; Gentili, Chiara (Frontiers Media, 2020-02-14)
    Osteoarthritis (OA) is a disabling joint disorder causing articular cartilage degeneration. Currently, the treatments are mainly aimed to pain and symptoms relief, rather than disease amelioration. Human bone marrow stromal ...
    Thumbnail

    TGF-ß1-Licensed Murine MSCs show superior therapeutic efficacy in modulating corneal allograft immune rejection In Vivo 

    Lynch, Kevin; Treacy, Oliver; Chen, Xizhe; Murphy, Nick; Lohan, Paul; Islam, Md Nahidul; Donohoe, Ellen; Griffin, Matthew D.; Watson, Luke; McLoughlin, Steven; O'Malley, Grace; Ryan, Aideen E.; Ritter, Thomas (Elsevier, 2020-05-29)
    Mesenchymal stromal cells (MSCs) are a promising therapeutic option for multiple immune diseases/disorders; however, efficacy of MSC treatments can vary significantly. We present a novel licensing strategy to improve the ...
    Thumbnail

    Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe 

    Griffin, Tomás P.; O'Shea, Paula M.; Smyth, Andrew; Islam, Md Nahidul; Wall, Deirdre; Ferguson, John; O'Sullivan, Esther; Finucane, Francis M.; Dinneen, Sean F.; Dunne, Fidelma P.; Lappin, David W.; Reddan, Donal N.; Bell, Marcia; O'Brien, Timothy; Griffin, Damian G.; Griffin, Matthew D. (BMJ Publishing Group, 2021-06-14)
    Introduction This study aimed to determine the prevalence of diabetic kidney disease (DKD) and rapid renal function decline and to identify indices associated with this decline among adults attending a diabetes center in ...
    Thumbnail

    Effects of mesenchymal stromal cells on regulatory T cells: Current understanding and clinical relevance 

    Negi, Neema; Griffin, Matthew D. (AlphaMed Press and Wiley, 2020-01-29)
    The immunomodulatory potential of mesenchymal stromal cells (MSCs) and regulatory T cells (T-reg) is well recognized by translational scientists in the field of regenerative medicine and cellular therapies. A wide range ...
    Thumbnail

    Editorial: Innovative biologics and drugs to target renal inflammation 

    Griffin, Matthew D.; Swaminathan, Sundararaman (Frontiers Media, 2020-02-06)
    [No abstract available]
    Thumbnail

    Mesenchymal stromal cell–based therapies for acute kidney injury: progress in the last decade 

    Fazekas, Barbara; Griffin, Matthew D. (Elsevier, 2020-01-28)
    A little over 10 years ago, the therapeutic potential of mesenchymal stromal cells (MSCs) for the treatment of acute kidney injury (AKI) was becoming widely recognized. Since then, there has been further intensive study ...
    Thumbnail

    Progress toward the clinical application of mesenchymal stromal cells and other disease-modulating regenerative therapies 

    Hickson, LaTonya J.; Herrmann, Sandra M.; McNicholas, Bairbre A.; Griffin, Matthew D. (American Society of Nephrology, 2021-01-27)
    Drawing from basic knowledge of stem cell biology, embryonic development, wound healing and aging, regenerative medicine seeks to develop therapeutic strategies that complement or replace conventional treatments by actively ...
    Thumbnail

    Current good manufacturing practice considerations for mesenchymal stromal cells as therapeutic agents 

    Sanz-Nogués, Clara; O'Brien, Timothy (Elsevier, 2021-05-05)
    Producing human mesenchymal stromal cells (MSCs) for clinical use requires adherence to current good manufacturing practice (cGMP) standards. This is necessary for ensuring standardization and reproducibility through the ...
    • 1
    • 2
    • Copyright @ NUI Galway
    • Library
    • NUI Galway